Surgical versus medical castration in the treatment of metastatic prostate cancer; A systematic review and meta-analysis

被引：0
|
作者：
O'Sullivan, N. [1 ]
Temperley, H. C. [1 ]
Davey, M. G. [1 ]
Naughton, A. P. [1 ]
Casey, R. G. [1 ]
机构：
[1] Tallaght Univ Hosp, Dept Urol, Dublin, Ireland
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0997
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Surgical versus medical castration in the treatment of metastatic prostate cancer: A systematic review and meta-analysis
    O'Sullivan, Niall J.
    Temperley, Hugo C.
    Davey, Matthew G.
    Naughton, Ailish
    Casey, Rowan G.
    JOURNAL OF CLINICAL UROLOGY, 2023,
  • [2] Surgical Versus Medical Castration for Metastatic Prostate Cancer; A Systematic Review And Meta-Analysis
    O'Sullivan, Niall J.
    Temperley, Hugo
    Naughton, Ailish
    Casey, Rowan G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S223 - S224
  • [3] Abiraterone for Treatment of Metastatic Castration-resistant Prostate Cancer: a Systematic Review and Meta-analysis
    Zhou, Zhi-Rui
    Liu, Shi-Xin
    Zhang, Tian-Song
    Xia, Jun
    Li, Bo
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (03) : 1313 - 1320
  • [4] Combination therapy in metastatic castration sensitive prostate cancer: A Systematic review and network meta-analysis
    Kumar, Jatinder
    Alam, Muhammad Umar
    Jazayeri, Seyed Behzad
    Tanneru, Karthik
    Bazargani, Soroush
    Shastri, Charu
    Gautam, Shiva
    Koochekpour, Shahriar
    Shukla, Sanjeev
    Bandyk, Mark
    Costa, Joseph
    Balaji, K. C.
    INDIAN JOURNAL OF UROLOGY, 2022, 38 (03) : 220 - 226
  • [5] Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis
    Fallara, Giuseppe
    Belladelli, Federico
    Robesti, Daniele
    Raggi, Daniele
    Nocera, Luigi
    Marandino, Laura
    Galsky, Matthew D.
    Montorsi, Francesco
    Malavaud, Bernard
    Ploussard, Guillaume
    Necchi, Andrea
    Martini, Alberto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 179
  • [6] PARP inhibitor-based treatment in metastatic, castration-resistant prostate cancer (mCRPC): A systematic review and meta-analysis
    Roberto, Michela
    Di Civita, Mattia Alberto
    Marinelli, Daniele
    Torchia, Andrea
    Cara, Nertila
    Maltese, Giulia
    Speranza, Iolanda
    Santini, Daniele
    BJUI COMPASS, 2025, 6 (01):
  • [7] Efficacy and Safety of Abiraterone Acetate and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
    Wei, ZhenHeng
    Chen, ChuXin
    Li, BoWen
    Li, YongYue
    Gu, Hong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] The current role of local treatment in metastatic prostate cancer: systematic review and meta-analysis
    Baccaglini, Willy
    Rodrigues, Antonio F.
    Teles, Saulo B.
    Christofe, Nicolle M.
    Glina, Felipe P. A.
    Lemos, Gustavo C.
    Sanchez-Salas, Rafael
    Olivares, Ruben
    Carneiro, Arie
    ACTA ONCOLOGICA, 2022, 61 (11) : 1386 - 1393
  • [9] The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis
    Wang, Yi
    Qin, Zhiqiang
    Wang, Yamin
    Chen, Chen
    Wang, Yichun
    Meng, Xianghu
    Song, Ninghong
    BIOSCIENCE REPORTS, 2018, 38
  • [10] Evaluation of the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
    Wu, Kan
    Liang, Jiayu
    Shao, Yanxiang
    Xiong, Sanchao
    Feng, Shuyang
    Li, Xiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345